Page 18 - கேம்பிரிட்ஜ் ஒன்றுபட்டது கிஂக்டம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Gamma Biosciences Announces Strategic Licensing Agreement by Astrea Bioseparations for Advanced Application of Avacta Affimer® Reagent Technology News provided by Share this article Share this article MENLO PARK, Calif. and CAMBRIDGE, United Kingdom, Dec. 21, 2020 /PRNewswire/ Gamma Biosciences, a life sciences tools platform created by KKR, today announced a licensing agreement between Astrea Bioseparations, a leader in affinity chromatography and bioseparations, and Avacta, a developer of innovative cancer therapies and diagnostics based on proprietary Affimer® and preCISION™ platforms. The licensing agreement gives Astrea access to the Affimer technology for applications in bioprocessing, expanding its range of ligand discovery and development capabilities to include best-in-class chemical and biological platforms for customer development programs.

United statesUnited kingdomBritish islesUnited kingdom generalAlastair smithAstrea bioseparationsBeth willersSteve burtonPhil vanekAvacta groupPrometic bioseparations ltdAstrea bioseparations ltdBruce dawsonGamma biosciencesCambridge united kingdomஒன்றுபட்டது மாநிலங்களில்